PARTICULARITIES OF ORAL HEALTH PROBLEMS IN PATIENTS WITH ALZHEIMER`S DEMENTIA

  • Mihaela Monica SCUTARIU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ilinca UNTU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Amelia SURDU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Oana Elena CIURCANU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Alexandra BOLOS “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

Aim: Dementia and especially Alzheimer`s dementia represent one of the most important disorder of this century with a lot of negative consequences for the patient himself, but also for family and community. The essential features of dementia are represented by multiple cognitive deficits, at least one of the following: aphasia, apraxia, agnosia, or a disturbance in executive, which diminished the quality of life of these patients. Unfortunately, in majority of the cases, the oral health care of these patients does not represent a priority. The aim of our study is to establish a series of general coordinates on the pattern of development of oral diseases in patients with dementia. Material and methods: We focused on the clinical evolution of 50 patients from “Socola” Institute of Psychiatry Iasi, with the diagnosis of Alzheimer`s dementia, according to ICD 10 criteria, from the point of view of the general and dental status, the prognosis and the therapeutic possibilities. Results: Our results reveal that 78% of patients with moderate dementia had partial and total edentation and 56% of patients with severe dementia had partial edentation, while 21% total edentation. Conclusions: Thus, in this context, increasing the quality of life of these patients means to improve the general condition of the elderly, which is closely related to the maintenance of natural teeth and the development of well-adapted prostheses.

Author Biographies

Mihaela Monica SCUTARIU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Dental Medicine
Department of Implantology, Removable Prosthesis, Dental Prosthesis Technology

Ilinca UNTU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (III)

Amelia SURDU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Dental Medicine
Department of Implantology, Removable Prosthesis, Dental Prosthesis Technology

Oana Elena CIURCANU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Dental Medicine
Department of Oral and Maxilo-facial Surgery

Alexandra BOLOS, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (III)

References

1. ***The World Alzheimer Report. The Global Impact of Dementia: An analysis of prevalence, inci-dence, cost and trends 2015.https://www.alz.co.uk/research/world-report-2015.
2. Szalontay A, Burtea V, Ifteni P. Predictors of Institutionalization in Dementia. Rev Cercet Interv Socială 2015; 49: 249-256.
3. Crețu OC, Szalontay AS, Mircea R, Chiriță V, Chiriță R. Ethical-normative conceptual evaluation in assisting people affected by Alzheimer disease. Rev Rom Bioetică 2010; 8(2): 134-140.
4. Knopman DS et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Neurology 2001; 56(9): 1143-1153.
5. Ungureanu E, Nechita P. Frîncu RM., Szalontay AS. Dementia-ethical and legal implications in psychiatric medical assistance. Case report. Rev Med Chir Soc Med Nat Iasi 2017; 121(1): 83 - 88.
6. McDowell I. Alzheimer's disease: insights from epidemiology. Aging 2001; 13(3): 143-162.
7. ***American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th Edition. American Psychiatric Publishing, Inc: Washington, DC, 2013.
8. Crețu O., Szalontay AS., Chiriță R., Chiriță V. Effects of memantine treatment on patients with mod-erate severe Alzheimer disease treated with donepezil. Rev Med Chir Soc Med Nat Iasi 2008; 112(3): 641-645.
9. Pasinetti GM. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. J Alz-heimers Dis 2002; 4(5): 435-445.
10. Szalontay AS, Dima-Cozma C, Chele G, Crețu O, Chiriță R, Jordanova V. Diabetes and obesity - risk factors for dementia? Bul Psih Integrativă 2012; 18(2): 58-66.
11. Călin AM, Debita M, Dragomir R, Stefanescu OM, Budacu C, Szalontay AS. Treatment methods conditioned by the gravity of drug- induced gingival hyperplasia. Rev Chimie 2017; 68(11): 2618-2622.
12. Cerutti-Kopplin D et al. Tooth Loss Increases the Risk of Diminished Cognitive Function: A System-atic Review and Meta-analysis. JDR Clin Translational Res 2016; 1(1): 10-19.
13. Beldiman MA, Tatarciuc MS, Bosânceanu DN, Macovei G, Luchian I, Mârțu I. Quality of life and psychological and social aspects for elderly patients-the oral health impact profile questionnaire. J Oral Rehabilitation 2017; 9(1): 39-46.
14. Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D. et al. Periodontitis and Cognitive Decline in Alzheimer’s Disease. PLoS ONE 2016; 11(3): e0151081.
15. Naorungroj S. et al. Tooth loss, periodontal disease, and cognitive decline in the Atherosclerosis Risk in Communities (ARIC) study. Community Dent Oral Epidemiol 2015; 43(1): 47-57.
16. Takeuchi K. et al. Tooth Loss and Risk of Dementia in the Community: the Hisayama Study. JAGS 2017; 65(5): 95-100.
17. ***World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD) 10th revision. 1992.
18. Harding A, Robinson S, Crean J, Singhrao SK. Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer’s Disease? J Alzheimer's Dis 2017; 58(2): 337-348.
19. Călin AM., Debita M., Ciurcaru OE., Scutariu MM., Szalontay AS. Xerostomia and Hyposalivation in Patients with Physical and Psychopathological Disabilities. Rev Chimie 2017; 68(10): 2443-2447.
20. Dima-Cozma C., Mitu F., Szalontay A., Cojocaru DC. Socioeconomic Status and Psychological Factors in Patients with Essential Hypertension. Rev Cercet Interv Socială 2014; 44: 147-159.
21. Okamotoa N. et al. Association between Tooth Loss and the Development of Mild Memory Impairment in the Elderly: The Fujiwara-kyo Study. J Alzheimer’s Disease 2015; 44: 777-786.
22. Scutariu MM, Surdu A, Macovei G. Methods of integrating aesthetic rehabilitation into the treatment plan of elderly patients. Rev med Chir Soc Med Nat Iasi 2015; 119(2): 557-563.
23. Popovac A, Stancic I, Despotovic N, Nikolic N, Stefanova E, Milasin J. Differnec in apolipoprotein E genotype distribution between dentate and edentulous elderly patients with Alzheimer disease. Genetika 2016; 48(2): 699-706.
24. 24.Fereshtehnejad S.M. et al. Dental care utilization in patients with different types of dementia: A longitudinal nationwide study of 58,037 individuals. Alzheimer and dementia 2018; 14(1): 10-19.
25. Ghezzi E., Ship J. Dementia and oral health. Oral Surg Oral Med Oral Pathol Oral Radiol 2000; 89: 2-5.
26. Campos C.H. et al. Mastication and oral health-related quality of life in removable denture wearers with Alzheimer disease. J Prosthet Dent 2017; 118(3): 251-262.
Published
2018-06-30